Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » Factors affecting lung transplant success for people with Interstitial Lung Disease (ILD)
A summary of research published in BMJ Open Respiratory Research
Lung transplants are common for people with interstitial lung disease (ILD). The length of time a person continues to live after their transplant, known as the survival rate, can be very different. A new study has looked at how a number of factors affect survival rate.
What did the study look at?
Researchers gathered information from 284 people who received a lung transplant for ILD at a centre in the UK. They collected data from three different time periods: 1987–2000, 2001–2010 and 2011–2020. A range of factors were looked at including a person’s age, the type of ILD they had and whether they received a transplant of one or both lungs.
What do the results show?
Key findings include:
Why is this important?
This study outlines factors that affect the number of years a person will live after they receive a lung transplant. It gives a detailed picture by looking at over 30 years of data.
The study confirms that the survival times after a lung transplant can be affected by many factors. This finding supports the need for multidisciplinary teams to make decisions about who should receive a transplant. This is so that all factors can be considered.
The findings also support the idea that a transplant of a single lung is still a valid option for people aged over 50.
Read the original research paper:
Lung transplantation for interstitial lung disease: evolution over three decades
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79